Human Longevity: Longevity Focused Company Completes $39.8 Million (Upsized Series B) Funding Round
Human Longevity Inc. (HLI), a longevity-focused technology company, announced today the completion of an oversubscribed $39.8M Series B round led by TVM Capital Healthcare with participation from new and existing investors, including Panacea Venture and Emerging Technology Partners. This funding round will invest in HLI’s artificial intelligence health risk and recommendation platform, new longevity-focused technologies and services, and new expansion sites globally.
Read More from the Global Wellness News ™